Mitochondrial health supplements have moved from fringe longevity stacks to a genuine area of clinical research. CoQ10, PQQ, NAD+ precursors, and urolithin A each target distinct pathways in mitochondrial function — and the evidence base for each varies significantly in strength and specificity.
Mitochondria don't just produce energy. They regulate cell survival, inflammation, metabolic rate, and hormonal balance. As we age, mitochondrial function declines — a process implicated in everything from fatigue and cognitive decline to metabolic dysfunction. Whether supplementation can meaningfully reverse or slow that decline is the question this evidence review addresses.
This article covers what published research actually found — not promised outcomes. Every finding cited below reflects peer-reviewed evidence framed as evidence, not a promise of clinical outcomes. Individual results vary.
Why Mitochondrial Health Matters for Longevity
Mitochondria are the primary site of ATP synthesis (cellular energy production) via oxidative phosphorylation. They also regulate apoptosis (programmed cell death), reactive oxygen species (ROS) production, and calcium signaling. When mitochondrial function declines — a condition broadly called mitochondrial dysfunction — cells produce less ATP, accumulate oxidative damage faster, and lose the ability to clear damaged organelles.
Aging is consistently associated with reduced mitochondrial density, impaired electron transport chain efficiency, and accumulation of mitochondrial DNA mutations. Research in longevity biology has identified mitophagy (selective clearance of damaged mitochondria) and mitochondrial biogenesis (creation of new mitochondria) as two key processes to support. The supplements reviewed below each address one or more of these targets.
CoQ10 and Ubiquinol: The Foundational Mitochondrial Antioxidant
Coenzyme Q10 (CoQ10) is a fat-soluble compound intrinsic to the mitochondrial electron transport chain. It transfers electrons between complexes I, II, and III — a step essential to ATP synthesis. Endogenous CoQ10 levels decline with age and are further depleted by statin medications.
A 2022 systematic review in Nutrients examined CoQ10 supplementation across multiple cohorts and found consistent improvements in biomarkers of mitochondrial respiratory function in adults over 50. Ubiquinol — the reduced, active form of CoQ10 — demonstrated superior bioavailability in pharmacokinetic comparisons, particularly in older subjects who have reduced enzymatic capacity to convert ubiquinone to ubiquinol.
Standard oral doses in research range from 100–300 mg daily. CoQ10 is generally well-tolerated; its interaction with anticoagulant medications warrants provider discussion before starting. Any supplementation protocol is subject to evaluation by a licensed provider.
PQQ: Mitochondrial Biogenesis and the 2026 Research Landscape
Pyrroloquinoline quinone (PQQ) is a redox cofactor that stimulates mitochondrial biogenesis — the growth of new mitochondria — primarily through activation of the SIRT1 and PGC-1α pathway. This distinguishes it from CoQ10, which supports existing mitochondrial function, and from NAD+ precursors, which work upstream on NAD-dependent enzymes.
A 2026 review published in Ageing Research Reviews directly compared the anti-aging mechanisms of PQQ and NMN/NR as potential combination candidates. The authors found PQQ's primary mechanism — SIRT1/PGC-1α-mediated mitochondrial biogenesis — is complementary to NMN/NR's mechanism of NAD+ repletion, suggesting potential additive effects when combined. The review noted preclinical evidence is stronger than human trial data for PQQ specifically, and called for larger randomized controlled trials.
Human studies with PQQ at 10–20 mg/day have shown improvements in cognitive function scores and energy-related self-report measures. The evidence base is smaller than CoQ10 but mechanistically compelling.
NAD+ Precursors (NMN and NR): Restoring a Critical Metabolic Coenzyme
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to mitochondrial function, DNA repair, and sirtuin activation. NAD+ levels decline approximately 50% between ages 40 and 60 in human tissues. NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are dietary precursors that can restore NAD+ levels without directly supplying NAD+.
A 2023 clinical review published on PubMed Central analyzed human supplementation trials with NAD+-boosting compounds and found that NMN and NR supplementation is safe, well-tolerated, and capable of measurably increasing NAD+ levels in multiple tissues. The clinical significance of those increases in terms of longevity outcomes in healthy adults is still under investigation in ongoing trials.
For a detailed comparison of NMN and NR specifically, see our guide to NMN vs. NR: which NAD+ precursor works better. Our broader article on NAD+ therapy via telehealth covers clinical protocol options subject to provider evaluation.
Urolithin A: The Mitophagy Activator
Urolithin A is a gut-derived metabolite produced when the gut microbiome processes ellagitannins from foods like pomegranates, walnuts, and berries. Not everyone produces urolithin A efficiently — gut microbiome composition determines whether dietary ellagitannins convert to this active form. Supplemental urolithin A bypasses that dependency.
A 2022 randomized clinical trial published in Nature Metabolism found that urolithin A supplementation activated mitophagy gene expression and improved mitochondrial gene expression in skeletal muscle of older adults. The study also noted improved muscle endurance markers in the supplemented group. This is among the more compelling recent human data for a mitochondria-targeted supplement — it was a well-controlled RCT rather than a preclinical or observational study.
Urolithin A's mechanism is distinct from CoQ10 and PQQ: it activates mitophagy pathways (PINK1/Parkin), clearing damaged mitochondria rather than producing new ones or supporting existing function. In principle, a protocol combining urolithin A with a biogenesis-activating compound like PQQ could address both clearing damaged mitochondria and generating healthy ones.
| Supplement | Primary Mechanism | Strength of Evidence | Key Finding |
|---|---|---|---|
| CoQ10 / Ubiquinol | Electron transport chain support, antioxidant | Moderate (multiple trials) | Improved mitochondrial respiratory markers in aging adults; ubiquinol shows superior bioavailability |
| PQQ | Mitochondrial biogenesis via SIRT1/PGC-1α | Emerging (strong preclinical, limited human RCTs) | Stimulates new mitochondria formation; cognitive benefits in small trials; complementary to NMN/NR per 2026 review |
| NMN / NR (NAD+ precursors) | NAD+ repletion, sirtuin activation | Moderate (growing RCT base) | Safely increases NAD+ levels in multiple tissues; longevity outcome significance in healthy adults under investigation |
| Urolithin A | Mitophagy activation (PINK1/Parkin pathway) | Moderate (quality 2022 RCT) | Activated mitophagy genes and improved muscle endurance in older adults; microbiome-independent via supplementation |
| Exercise (resistance + HIIT) | Mitochondrial biogenesis and mitophagy | Strong (extensive RCT literature) | Most robustly evidenced intervention for mitochondrial health; supplements augment, not replace, this foundation |
Mitochondrial Peptides: MOTS-c and Humanin
Beyond conventional supplements, emerging research covers mitochondria-derived peptides — short proteins encoded within mitochondrial DNA itself. MOTS-c has been studied for its role in metabolic regulation and insulin sensitivity, while Humanin shows cytoprotective effects in multiple cell models. Both are preclinical or early-stage in terms of human data.
For deeper dives, see our research summaries on MOTS-c mitochondrial peptide research. These are not FDA-approved compounds; all use is subject to medical approval by a licensed provider.
What the Research Does Not Show
Transparency matters here. Current mitochondrial health supplement research has several consistent gaps worth noting:
- No supplement has demonstrated extended human lifespan in a controlled trial. Most evidence comes from biomarker improvements, not mortality data.
- Effect sizes in human trials are often modest. The biggest single intervention for mitochondrial function remains exercise — specifically resistance training and high-intensity interval training.
- Combination protocol data is sparse. The 2026 PQQ + NMN/NR review called for trials on combined use; most human data covers individual compounds.
- Bioavailability varies significantly. Ubiquinol vs. ubiquinone, NR vs. NMN absorption, and urolithin A microbiome dependency all affect individual response to the same dose.
Studies suggest each compound addresses real mitochondrial targets. The honest read of the literature is: these supplements are mechanistically sound, mostly safe at studied doses, and show consistent (if modest) biomarker effects. Longevity outcomes in healthy human populations remain a research question, not a settled claim.
Frequently Asked Questions
What supplements support mitochondrial health?
The most studied mitochondrial health supplements include CoQ10 (ubiquinol form for better bioavailability), PQQ, NAD+ precursors (NMN and NR), and urolithin A. Each targets a distinct pathway: CoQ10 supports electron transport, PQQ stimulates biogenesis, NMN/NR replete NAD+ levels, and urolithin A activates mitophagy. Any supplementation should be discussed with a licensed provider before starting.
Does CoQ10 actually work for energy?
Trials show CoQ10 improves mitochondrial respiratory chain biomarkers and is beneficial in populations with documented CoQ10 depletion — including statin users and older adults. Subjective energy improvements are reported but harder to isolate. Ubiquinol (the active reduced form) shows superior pharmacokinetics in older adults and is preferred in most protocols for this age group. Studies suggest effects are meaningful, though individual response varies.
What is PQQ and how does it differ from CoQ10?
PQQ (pyrroloquinoline quinone) stimulates the growth of new mitochondria (biogenesis) via the SIRT1/PGC-1α pathway. CoQ10 supports the function of existing mitochondria as a component of the electron transport chain. They act through different mechanisms and are potentially complementary. A 2026 review in Ageing Research Reviews highlighted PQQ's complementarity with NMN/NR as well.
How does NAD+ support mitochondrial function?
NAD+ is a coenzyme essential to several steps of the mitochondrial electron transport chain and is required for sirtuin enzymes (SIRT1-3) that regulate mitochondrial biogenesis and stress response. NAD+ levels decline with age. NMN and NR supplementation restores NAD+ levels in human tissues based on clinical trial data, though longevity effects in healthy adults are still under investigation.
Can you reverse mitochondrial dysfunction with supplements?
Available evidence suggests supplements can improve specific mitochondrial function biomarkers and may slow aspects of age-related decline. Whether this translates to reversal of clinically meaningful dysfunction in humans is not yet demonstrated. Preclinical models show more dramatic effects than human trials. Exercise remains the most robustly evidenced single intervention for mitochondrial health.
What causes mitochondrial decline with aging?
Age-related mitochondrial decline reflects accumulated mitochondrial DNA mutations, declining NAD+ levels, reduced PGC-1α activity (reducing biogenesis), decreased CoQ10 concentrations, and impaired mitophagy that allows damaged mitochondria to accumulate. These are overlapping rather than isolated causes, which is why combination approaches addressing multiple pathways are being investigated.
What is urolithin A and why is it significant?
Urolithin A is a gut-derived compound produced from ellagitannins found in pomegranates, walnuts, and berries. Its significance is in activating mitophagy — selective clearance of damaged mitochondria via the PINK1/Parkin pathway. A 2022 RCT in Nature Metabolism found urolithin A supplementation activated mitophagy gene expression and improved muscle endurance in older adults. Not everyone produces urolithin A from food; direct supplementation bypasses the microbiome dependency.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.